Director, Strategic Forecasting, Oncology

The Role Moderna continues to expand its innovative mRNA platform, unlocking new applications across diseases and therapeutic areas. As the company advances its oncology pipeline, including a personalized mRNA therapy intismeran in collaboration with Merck, a Phase 2 off-the-shelf cancer therapy (mRNA-4359), and additional cancer antigen therapies (mRNA-4106 and mRNA-4203) entering Phase 1, this role will play a critical part in shaping portfolio decisions. Moderna is seeking a Director of Strategic Forecasting to lead global revenue forecasting for its oncology portfolio, spanning early research through launch readiness. This high-impact individual contributor role sits within the Commercial organization and supports investment decisions, portfolio planning, and long-range forecasting for pipeline assets as well as operational US forecasting for intismeran. This role partners closely with R&D, Commercial, Finance, and CMC to deliver operational and strategic forecasts, scenario plans, and market insights that shape Moderna’s direction in oncology. You combine strong analytical expertise with deep oncology domain knowledge and are comfortable translating uncertainty into actionable insights. You are a collaborative thinker who thrives in complex, cross-functional environments and brings a proactive mindset to decision support. Here's What You’ll Do Partner with alliance stakeholders at Merck to develop strategic and operational forecasts for intismeran and define KPIs to track launch performance. Develop revenue forecasts focused on the oncology pipeline to inform decision-making from preclinical research through commercialization. Deliver scenario analyses and contextualize uncertainty to support key strategic decisions and leadership planning. Generate deep insights on products and markets of interest through secondary and primary research and data analytics (partnering with insights functions as needed). Serve as a forecasting partner to cross-functional stakeholders in R&D, Finance, CMC and Commercial to contribute forecasting insights in cross-functional forums. Drive integration of program-level forecasts into broader portfolio models and long-range planning frameworks, in close collaboration with Finance and Strategy teams, to support operational alignment and strategic decision-making. Stay ahead of industry trends, competitive developments, and market dynamics to provide forward-looking insights and shape strategic planning. Support portfolio investment decisions by delivering evidence-based forecasts and scenario models that reflect market dynamics and clinical development risk. Here’s What You’ll Need (Basic Qualifications) 8 years of experience in forecasting, analytics or strategic planning within the biopharmaceutical or life sciences industry, with exposure to multiple stages of drug development. Bachelor’s degree in business, life sciences, or a related field. Strong expertise in revenue forecasting, including applications across pipeline programs, inline products, and enterprise planning. Experience supporting LRP, LE, or other enterprise-level financial and operational planning processes Experience in gathering various types of insights (secondary research, primary research, data analytics etc.) and integrating them to inform forecasting assumptions and strategic questions. Strong familiarity with the oncology market dynamics. Knowledge of oncology-specific datasets covering market landscape, competitive intelligence, real-world product utilization, prescription behavior etc. Here’s What You’ll Bring to the Table (Preferred Qualifications) Advanced degree (MBA, MS, PhD) preferred. Launch performance metrics development experience a plus. Prior consulting and/or market research/ CI/ analytics experience is a plus. Prior oncology forecasting experience strongly preferred, particularly in early-stage or novel modalities. Strategic thinking skills with the ability to synthesize complex ... (truncated, view full listing at source)